Genomics Market by Product Types, Services - 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Genomics market
Genomics Market Analysis: Product Types (DNA Microarrays, Sequencers, PCR); Services (Bioinformatics, DNA Sample Sequencing, De Novo, SNPS, Gene Expression) and Geography - Forecast (2015 - 2020).
Report Code : HCR 0027
Published: 17 January, 2015   No. of pages: 163

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Genomics is the branch of biology that deals with collection of genetic data and understanding the genomic patterns present in DNA, a double-helical structure that defines us and our existence. Genomics has been in existence for a long time and it has shown the promise of a better future for the mankind. The ambitious Human Genome Project which got completed in 2003 is the biggest study ever conducted sequencing over 3 billion base pairs. The reason genomics has gained traction is because of its ability to analyze the genetic code, the variations that cause diseases and the possible solution for maximizing the longevity of life. Keeping classical genetics as the fundamental principle, Genomics has come a long way in garnering global attention.

Genomics Market

The pharmaceutical industry is one of the prominent end user segments for genomics market. With the introduction of biomarkers in drug discovery, the market has garnered attention from pharmaceutical firms. The industry is moving towards the concept of personalized medicine which involves identifying the genomic sequence to provide right drugs with correct dosage. With gene sequencing, the entire genome sequence can be analysed for mutations which cause diseases such as Cancer or Diabetes.

This market has been analyzed by product types analysis such as:
  • Chromatography
  • DNA sequencers
  • Electrophoresis
  • DNA microarrays
  • X-Ray Crystallography and
  • Polymerase Chain Reaction

The following key companies were analyzed in the report:
  • Roche Diagnostics
  • Life Technologies
  • Illumina Inc
  • Qiagen
  • Bio-Rad Laboratories

In this report, the Genomics market is further segmented into service industry, end user and geography. Service industry include Bio-informatics database, Bio-informatics tools, De Novo Sequencing, Genotyping service, DNA Sample Sequencing and Biomarker solutions. Major end users wherein genomics is widely used are anthropology, agriculture, cytogenetics, diagnostics, drug discovery and Toxicogenomics.

1. Genomics – Market Overview
   1.1. Introduction
   1.2. By Product Type Analysis
   1.3. Service Industry Analysis
   1.4. By End User Analysis
   1.5. By Geography
2. Genomics Market - Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End-User Profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Global Genomics Market – Market Forces
   4.1. Market Drivers
      4.1.1. Increasing Investment in Pharmaceutical Industry
      4.1.2. Government Initiatives to Promote Genomics
      4.1.3. Reduction in Sequencing Costs
   4.2. Market Constraints
      4.2.1. Uncertainity in Regulatory Approvals
   4.3. Market Challenges
      4.3.1. Lack of Necessary Tools for Analysis
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substituion
      4.4.5. Degree of Competition
5. Genomics Market- Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunity Analysis
      5.2.1. Precision Medicine and Mining Are the Next Frontiers of Growth
   5.3. Market Life Cycle Analysis
   5.4. Supplier Distributor Analysis
6. Genomics Market- By Product Type
   6.1. Introduction
   6.2. Products
      6.2.1. DNA Microarrays
      6.2.2. Electrophoresis
      6.2.3. X-Ray Crystallography
      6.2.4. Polymerase Chain Reaction (Pcr)
      6.2.5. DNA Sequencers
      6.2.6. Chromatography
   6.3. Reagents Used
7. Genomics Market – Service Industry Analysis
   7.1. Introduction
   7.2. Bio-Informatics Database
   7.3. Bio-Informatics Tools
   7.4. Laboratory Services
      7.4.1. DNA Sample Sequencing
      7.4.2. De Novo Sequencing
      7.4.3. Targeted Re-Sequencing
      7.4.4. Individual Genome Sequencing
      7.4.5. Snps Analysis
      7.4.6. Molecular Biology
      7.4.7. Gene Expression Analysis
      7.4.8. Genotyping Service
      7.4.9. Biomarker Solutions
8. Genomics Market – End User Application
   8.1. Introduction
   8.2. Anthropology
   8.3. Agriculture
   8.4. Cytogenetics
   8.5. Diagnostics
   8.6. Drug Discovery
   8.7. Toxicogenomics
   8.8. Others
9. Genomics Market – By Geography
   9.1. Introduction
   9.2. Americas
   9.3. Europe
   9.4. APAC
   9.5. ROW
10. Genomics Market – Market Entropy
   10.1. Most Preferred Strategy – New Product Launches
   10.2. Partnerships
11. Genomics Market - Company Profiles
   11.1. Luminex Corporation
      11.1.1. Business Overview
      11.1.2. Financials
      11.1.3. Products
      11.1.4. Developments
   11.2. Myriad Genetics Inc
      11.2.1. Business Overview
      11.2.2. Financials
      11.2.3. Products
      11.2.4. Developments
   11.3. Thermo Fisher Scientific Inc.
      11.3.1. Business Overview
      11.3.2. Financials
      11.3.3. Products
      11.3.4. Developments
   11.4. Pacific Biosciences of California, Inc
      11.4.1. Business Overview
      11.4.2. Financials
      11.4.3. Products
      11.4.4. Developments
   11.5. Ge Healthcare
      11.5.1. Business Overview
      11.5.2. Financials
      11.5.3. Products
      11.5.4. Developments
   11.6. Perkinelmer Inc.
      11.6.1. Business Overview
      11.6.2. Financials
      11.6.3. Products
      11.6.4. Developments
   11.7. Bayer Healthcare Llc
      11.7.1. Business Overview
      11.7.2. Products
      11.7.3. Financials
      11.7.4. Developments
   11.8. F. Hoffmann-La Roche Ltd
      11.8.1. Business Overview
      11.8.2. Financials
      11.8.3. Products
      11.8.4. Developments
   11.9. Illumina, Inc.
      11.9.1. Business Overview
      11.9.2. Financials
      11.9.3. Products
      11.9.4. Developments
   11.10. Agilent Technologies Inc.
      11.10.1. Business Overview
      11.10.2. Financials
      11.10.3. Products
      11.10.4. Developments
   11.11. Bio-Rad Laboratories
      11.11.1. Business Overview
      11.11.2. Financials
      11.11.3. Developments
   11.12. Qiagen N.V.
      11.12.1. Business Overview
      11.12.2. Financials
      11.12.3. Products
      11.12.4. Developments
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Acronyms
   12.2. Patents
      12.2.1. Genomics (2010-2015)
   12.3. Research Methodology
List of Tables:

Table 1. Genomic Sequencer Product Benchmarking, By Product Type
Table 2. Number of Patents Registered By Major Companies, 2010-2015
Table 3. Top 5 Fiancials Analysis: By Top 5 Players, 2014 ($Billion Except Eps)
Table 4. Global Genomics Market Revenue, By Product Type, 2014-2020 ($Million)
Table 5. Various Bioinformatics Tools
Table 6. Global Genomics Market Revenue, By End-Users, 2014-2020 ($Million)
Table 7. Global Genomics Market Revenue, By Region, 2014-2020 ($Million)
Table 8. Genomics Market: New Product Launches
Table 9. Genomics Market: Partnerships

 
List of Figures:

Figure 1. Global Genomics Market, 2014-2020 ($Millionillion)
Figure 2. Genomics Market Share, By Geography, 2014 (%)
Figure 3. Genomics Market Share, By Key Players, 2014 (%)
Figure 4. Genomics Market Share, By End-Users, 2014-2020
Figure 5. Genomics Patent Analysis By Year, 2010-2015
Figure 6. DNA Sequencing Cost, 2002-2015
Figure 7. Genomics Market, Value Chain Analysis
Figure 8. Genomics Market, Market Life Cycle Analysis
Figure 9. Global DNA Microarrays Market Revenue, 2014-2020 ($Million)
Figure 10. Global Electrophoresis Market Revenue, 2014-2020 ($Million)
Figure 11. Global X-Ray Crystallography Market Revenue, 2014-2020 ($Million)
Figure 12. Global Polymerase Chain Reaction (Pcr) Market Revenue, 2014-2020 ($Million)
Figure 13. Global DNA Sequencers Market Revenue, 2014-2020 ($Million)
Figure 14. Global Chromatography Market Revenue, 2014-2020 ($Million)
Figure 15. Bio-Informatics Database Market Revenue, By Year, 2014-2020 ($Million)
Figure 16. Bio-Informatics Tools Market Revenue, By Year, 2014-2020 ($Million)
Figure 17. Laboratory Services Market Revenue, By Year, 2014-2020 ($Million)
Figure 18. DNA Sample Sequencing Market Revenue, By Year, 2014-2020 ($Million)
Figure 19. De Novo Sequencing Market Revenue, By Year, 2014-2020 ($Million)
Figure 20. Targeted Re-Sequencing Market Revenue, By Year, 2014-2020 ($Million)
Figure 21. Individual Genome Sequencing Market Revenue, By Year, 2014-2020 ($Million)
Figure 22. SNPS Analysis Market Revenue, By Year, 2014-2020 ($Million)
Figure 23. Molecular Biology Market Revenue, By Year, 2014-2020 ($Million)
Figure 24. Gene Expression Analysis Market Revenue, By Year, 2014-2020 ($Million)
Figure 25. Genotype Service Market Revenue, By Year, 2014-2020 ($Million)
Figure 26. Biomarker Solutions Market Revenue, By Year, 2014-2020 ($Million)
Figure 27. Global Genomics Market Revenue, By Anthropology, 2014-2020 ($Million)
Figure 28. Global Genomics Market Revenue, By Agriculture, 2014-2020 ($Million)
Figure 29. Global Genomics Market Revenue, By Cytogenetics, 2014-2020 ($Million)
Figure 30. Global Genomics Market Revenue, By Diagnostics, 2014-2020 ($Million)
Figure 31. Global Genomics Market Revenue, By Drug Discovery, 2014-2020 ($Million)
Figure 32. Global Genomics Market Revenue, By Toxicogenomics, 2014-2020 ($Million)
Figure 33. Global Genomics Market Revenue, By Others, 2014-2020 ($Million)
Figure 34. Us Capital Invested in Genomics-Related Companies ($Million)
Figure 35. Americas Genomics Market Revenue, By Region, 2014-2020 ($Million)
Figure 36. UK Genomics-Related Spin-Out Companies, By Development Stage, 2014 (%)
Figure 37. UK Genomics and Genomics-Related Companies, By Location, 2014 (%)
Figure 38. Europe Genomics Market Revenue, By Region, 2014-2020 ($Million)
Figure 39. APAC Genomics Market Revenue, By Region, 2014-2020 ($Million)
Figure 40. Row Genomics Market Revenue, By Region, 2014-2020 ($Million)
Figure 41. Genomics Market, New Product Launches, 2013-15
Figure 42. Genomics Market New Product Launches, 2013-15 (%)
Figure 43. Luminex: Total Revenue, By Geography,  2012– 2014 ($Millionn)
Figure 44. Luminex: Total Revenue, By Region, 2014 (%)
Figure 45. Luminex: Total Revenue, By Segment, 2014 (%)
Figure 46. Financial Performance, 2012-2014, ($Million)
Figure 47. Myriad Genetics: Total Revenue, By Segment, 2014 (%)
Figure 48. Financial Performance, 2010-2014, ($Billion)
Figure 49. Thermo Fisher Scientific Inc.: Total Revenue, By Region, 2014 (%)
Figure 50. Thermo Fisher Scientific Inc.: Total Revenue, By Segment, 2014 (%)
Figure 51. Pacific Biosciences of California: Total Revenue, 2010– 2014, ($Million)
Figure 52. Pacific Biosciences of California: Total Revenue, By Region, 2010– 2014, (%)
Figure 53. GE Healthcare: Total Revenue,2012– 2014 ($Million)
Figure 54. GE Healthcare: Total Revenue,By Geography,2014 ($Million)
Figure 55. GE Healthcare: Total Revenue,By Sub- Segment,2014 ($Million)
Figure 56. Perkinelmer: Total Revenue,2012– 2014 ($Billion)
Figure 57. Perkinelmer: Total Revenue, By Region, 2014 (%)
Figure 58. Perkinelmer: Total Revenue, By Segment, 2014 (%)
Figure 59. Bayer Healthcare Llc, Financial Performance, 2012-2014($ Billion)
Figure 60. Bayer Healthcare Llc, Revenue, By Region 2014(%)
Figure 61. Roche: Total Sales, 2012-2014, ($Billion)
Figure 62. Roche: Total Sales, By Division, 2014 (%)
Figure 63. Illumina: Total Revenue, 2012-2014, ($Billion)
Figure 64. Illumina: Total Revenue, By Geography, 2014 (%)
Figure 65. Agilent: Net Revenue, 2012-2014, ($Billion)
Figure 66. Agilent: Net Revenue, By Business Segment, 2014 (%)
Figure 67. Agilent: Net Revenue, By Region, 2014 (%)
Figure 68. Bio-Rad Laboratories, Financial Performance, 2012-2014($ Billion)
Figure 69. Bio-Rad Laboratories, Revenue, By Region 2014(%)
Figure 70. Bio-Rad Laboratories, Revenue, By Segment 2014(%)
Figure 71. Qiagen: Revenue, 2012-2014($Billion)
Figure 72. Qiagen: Revenue, By Region 2014(%)
Figure 73. Qiagen, Revenue, By Segment 2014(%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports